Study finds no difference in adjuvant therapy strategiesContinuous aromatase inhibitor therapy no better than starting with tamoxifen Rethinking breast cancer FPs should take lead in reducing breast cancer risk Online tool helps family doctors screen women to detect higher-risk patients Chemo- trastuzumab combo ups survival Wait times for diagnosis exceed accepted targets Adjuvant therapy has feverish results in real-world care Febrile neutropenia observed at higher than expected rate Study OKs dose boost for estrogen receptor antagonist Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Statins benefit leukemia patients Clinical trials needed to pinpoint ideal candidates Groups collaborate on chronic disease prevention $15.5M invested in chronic disease prevention by Canadian Partnership Against Cancer First Previous 68 69 70 71 72 Next Last
